Molecular Dx firm GeneNews eyes $7.8M from share offering

12/18/2012 | GenomeWeb Daily News (free registration)

GeneNews, a molecular diagnostics firm based in Toronto, hopes to obtain $7.8 million in a private offering of its company stock. The company is in talks to expand the reach of its ColonSentry blood-based assay for colon cancer stratification, which is currently available in New York and New Jersey, across the rest of the U.S., President and CEO Gailina Liew said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY